Bronchial asthma is one of the most common chronic respiratory diseases in the world today, and it is roughly estimated that there are at least about 20 million asthma patients in China, and the prevalence rate is increasing year by year. Due to the high concentration of pollen in the air, the breeding of insects and mites, and the changes in cold, warm, sunny and rainy weather in spring, the triggering of bronchial asthma is significantly higher, so patients need to pay attention to it. In spring, asthma patients should pay attention to keep warm and cold, do not reduce clothes prematurely; reduce activities in public places, the chance of cross-infection in the crowd is high; avoid going to parks to reduce the stimulation of pollen; avoid going to new buildings to reduce the stimulation of paint; keep the living room clean and ventilated to reduce the triggering of dust and dust mites; pay attention to the combination of work and rest to avoid the decline of resistance. Of course, it is more important for doctors, families and the whole society to participate in the education and management of asthma patients, and to scientifically individualize and standardize the treatment according to the Global Initiative for Asthma Control (GINA) to achieve long-term control of the disease. With the advancement of basic, pharmacological and clinical research on asthma, it has been recognized in recent years that asthma is a chronic inflammatory disease of the airways involving multiple cells (e.g., eosinophils, mast cells, T lymphocytes, neutrophils, airway epithelial cells) and cellular components. This chronic inflammation differs markedly from bacterial inflammation and does not require long-term antimicrobial drug therapy, but rather the establishment of individual standardized glucocorticoid inhalation-based stepwise therapy. In patients with chronic persistent asthma, daily inhaled glucocorticoid-based therapy is used on the basis of the severity of the disease, and in moderately severe cases, combined with inhaled long-acting β2 agonist therapy, followed by (escalating or descending) step therapy depending on the control of the disease. Usually, after asthma control has been maintained for at least 3 months, step-down therapy can be tried to maintain symptom control with minimal medication. In the initial treatment of acute asthma exacerbations emphasis should be placed on repeated nebulized inhaled short-acting beta2 agonists (e.g., salbutamol, terbutaline) and judicious use of systemic glucocorticoids (e.g., hydrocortisone succinate or methylprednisolone). As acute asthma attacks vary in severity, some can be life-threatening within minutes. As many as 180,000 people die each year from acute asthma attacks worldwide, with the majority of them being young adults. Therefore, patients with a history of asthma should seek medical attention as soon as they experience chest tightness and increased wheezing to avoid delays in treatment. Although the danger of asthma is great, as long as you have a clear understanding of asthma, pay attention to the prevention and control aspects of asthma, correctly self-monitor your condition, and cooperate with your doctor to adhere to long-term standardized treatment, asthma can be completely controlled and you can work, live and study like a healthy person.